Publications by authors named "Hele Everaus"

Claim this Profile
S
Safety and efficacy of durvalumab with R-CHOP or R-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial.
Grzegorz S Nowakowski, Wolfgang Willenbacher, Richard Greil, Thomas S Larsen, Krish Patel, Hele Everaus

Int J Hematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia.
Markus Pfirrmann, Richard E Clark, Witold Prejzner, Michael Lauseker, Michele Baccarani, Hele Everaus

Leukemia· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia.
Heikki Kuusanmäki, Aino-Maija Leppä, Petri Pölönen, Mika Kontro, Olli Dufva, Hele Everaus

Haematologica· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing incidence and survival of corpus uteri cancer in Estonia over the past two decades.
Kristiina Ojamaa, Piret Veerus, Aleksei Baburin, Hele Everaus, Kaire Innos

Cancer Epidemiol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014.
Kristiina Ojamaa, Kaire Innos, Aleksei Baburin, Hele Everaus, Piret Veerus

BMC Cancer· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulfotransferase 1A1 as a Biomarker for Susceptibility to Carcinogenesis: From Molecular Genetics to the Role of Dietary Flavonoids.
Katrin Sak, Hele Everaus

Curr Drug Metab· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids.
Katrin Sak, Hele Everaus

Curr Genomics· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time Trends in Ovarian Cancer Survival in Estonia by Age and Stage.
Kristiina Ojamaa, Piret Veerus, Aleksei Baburin, Hele Everaus, Kaire Innos

Int J Gynecol Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute de novo Leukemia in Estonia and Western Sweden 1982-2006: Positive Trend in the Survival of Acute Leukemia over 25 Years.
Erik Hulegårdh, Mari Punab, Erik Holmberg, Katrin Palk, Edward Laane, Hele Everaus

Acta Haematol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentiation of luteolin cytotoxicity by flavonols fisetin and quercetin in human chronic lymphocytic leukemia cell lines.
Katrin Sak, Kristi Kasemaa, Hele Everaus

Food Funct· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemomodulating Effects of Flavonoids in Human Leukemia Cells.
Katrin Sak, Hele Everaus

Anticancer Agents Med Chem· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Target Cytotoxic Actions of Flavonoids in Blood Cancer Cells.
Katrin Sak, Hele Everaus

Asian Pac J Cancer Prev· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of flavonoids in future anticancer therapy by eliminating the cancer stem cells.
Katrin Sak, Hele Everaus

Curr Stem Cell Res Ther· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mathematical model of natural killer cell activity.
Anna Scherbakova, Helen Lust, Hele Everaus, Alar Aints

Cytometry A· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential population-based studies over 25 years on the incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1982-2006: a survey of patients aged ≥65 years.
Mari Punab, Katrin Palk, Mirja Varik, Edward Laane, Hele Everaus

Med Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients.
Judith E Raber-Durlacher, Inger von Bültzingslöwen, Richard M Logan, Joanne Bowen, Abdul Rahman Al-Azri, Hele Everaus

Support Care Cancer· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1997-2001: a survey of patients aged 16-64 years.
Lovisa Wennström, Soodabeh Safai-Kutti, Dick Stockelberg, Erik Holmberg, Katrin Palk, Hele Everaus

Acta Haematol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1997-2001: a survey of patients aged >or=65 years.
Katrin Palk, Ene Luik, Mirja Varik, Iige Viigimaa, Krista Vaht, Hele Everaus

Cancer Epidemiol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in the natural history of renal cancer: comparison of Estonian data from the periods 1986-1988 and 1996-1998.
Peeter Padrik, Ulle Kirsimägi, Hele Everaus

Int Urol Nephrol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapy.
Edward Laane, Asa Rangert Derolf, Elisabet Björklund, Joanna Mazur, Hele Everaus

Haematologica· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
Edward Laane, Edneia Tani, Elisabet Björklund, Göran Elmberger, Hele Everaus

Cytometry B Clin Cytom· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incidence and survival of acute de novo leukaemias in Estonia and in a well defined region of Western Sweden during 1982-1996: a survey of patients aged 16-64 years.
Lovisa Wennström, Eva-Lena Juntikka, Soodabeh Safai-Kutti, Dick Stockelberg, Erik Holmberg, Hele Everaus

Leuk Lymphoma· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nongenomic effects of 17beta-estradiol--diversity of membrane binding sites.
Katrin Sak, Hele Everaus

J Steroid Biochem Mol Biol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of P2Y receptors in the differentiation of haematopoietic cells.
Katrin Sak, Jean-Marie Boeynaems, Hele Everaus

J Leukoc Biol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis